Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Operating expenses:
Research and development	$ 21,088	$ 11,982
General and administrative	26,401	22,462
Total operating expenses	47,489	34,444
Loss from operations	(47,489)	(34,444)
Other income (expense), net
Interest and investment income	237	500
Interest expense		(34)
Other income (expense), net	237	466
Net loss	$ (47,252)	$ (33,978)
Net loss per share attributable to common stockholders, basic and diluted (in Dollars per share)	$ (4.21)	$ (4.7)
Weighted average shares outstanding, basic and diluted (in Shares)	11,232,576	7,233,913
Other comprehensive income (loss):
Net unrealized (loss) gain on marketable debt securities	$ (211)
Other comprehensive income (loss)	(211)
Comprehensive Loss	$ (47,463)	$ (33,978)